Clinical Trials Logo

Filter by:
NCT ID: NCT02912949 Recruiting - NRG1 Fusion Clinical Trials

A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

Start date: January 2015
Phase: Phase 2
Study type: Interventional

This is a Phase I/II, open-label, multi-center, multi-national, dose escalation, single agent study to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors harboring an NRG1 fusion (eNRGy)

NCT ID: NCT02909920 Recruiting - Clinical trials for Shoulder Impingement Syndrome

Effectiveness of Telerehabilitation Program in Subacromial Syndrome (Telerehab Sis)

telerehab
Start date: September 2016
Phase: N/A
Study type: Interventional

Shoulder pain is a common and high prevalence in the general population. Subacromial Syndrome (Shoulder Impingement Syndrome (SIS)) is the most frequent cause. SIS patients suffering pain, muscle weakness and loss of movement in the affected joint. Initial treatment of the SIS is predominantly conservative. Surgical option has high success rates and is often used when conservative strategy fails. Traditional Physiotherapy and Postoperative exercises is needed to the recovery of joint range, muscle strength, stability and functionality. This Research evaluates the feasibility and effectiveness of a telerehabilitatión Program in SIS after surgery compared with traditional therapy.

NCT ID: NCT02904733 Recruiting - HIV Infections Clinical Trials

Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE)

EMERGE
Start date: April 7, 2017
Phase: N/A
Study type: Interventional

A large (3900 patients) cohort study, undertaken in five European sites to validate in a mHealth platform to enable self-management of HIV in patients with stable disease using a tailored HTA process, Model for Assessment of Telemedicine Applications (MAST), specifically developed for the assessment of mHealth solutions. As site recruitment will be sequential and the recruitment period will last 18 months, a maximum follow-up of 35 Months will be undertaken. Study visits will take place at baseline defined as the time of mHealth introduction, months 6, 12, 18, 24 and 30.

NCT ID: NCT02904408 Recruiting - Hidradenitis Clinical Trials

Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality of Life

Start date: June 2016
Phase: N/A
Study type: Interventional

The aim of this study is to determine the benefits of group psychotherapy on quality of life for people with hidradenitis suppurativa receiving medical and surgical treatment versus a control group (awaiting group) treated with medical and surgical treatment, without psychotherapy.

NCT ID: NCT02903537 Recruiting - Clinical trials for Multiple Sclerosis, Relapsing-Remitting

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)

TOLERVIT-MS
Start date: July 6, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the safety and tolerability of the intranodal administration of autologous monocyte-derived dendritic cells tolerised with Vitamin-D3 and pulsed with myelin peptides (tolDC-VitD3) in multiple sclerosis patients . To select the most appropriate regime for the development of future therapeutic trials. To evaluate the preliminary proof of concept by clinical and/or radiological activity and immunological markers.

NCT ID: NCT02902653 Recruiting - Labor, Induced Clinical Trials

Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction

Start date: September 2016
Phase: Phase 4
Study type: Interventional

This study evaluates the efficacy and safety of the administration of oral misoprostol versus vaginal dinoprostone and vaginal misoprostol for cervical ripening and labor induction.

NCT ID: NCT02901392 Recruiting - Clinical trials for Urinary Incontinence, Stress

Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment

Start date: April 2004
Phase:
Study type: Observational [Patient Registry]

Stress urinary incontinence is a significant potential source of morbidity after radical prostatectomy or radiation therapy for prostate cancer. At present, artificial urinary sphincter remains the preferred therapeutic option. However, this technique is not free from complications. In an attempt to avoid such complications, male sling has been suggested for use in patients with mild degrees of stress incontinence.

NCT ID: NCT02889874 Recruiting - Clinical trials for Early Stage Breast Carcinoma

EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer

EXPERT
Start date: August 21, 2017
Phase: N/A
Study type: Interventional

This is a randomised, phase III, non-inferiority trial evaluating radiation therapy versus observation following breast conserving surgery and planned endocrine therapy in patients with stage I breast cancer of luminal A subtype defined using the Prosigna (PAM50) Assay.

NCT ID: NCT02882490 Recruiting - Tourette Syndrome Clinical Trials

Parent Behavioral Training for Disruptive Behaviors in Tourette Syndrome

Start date: June 2014
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to assess the efficacy of a parent training program to control disruptive behaviors in children with Tourette Syndrome.

NCT ID: NCT02879331 Recruiting - Pulmonary Emphysema Clinical Trials

Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils

CYCLONE
Start date: November 2016
Phase: N/A
Study type: Interventional

The study hypothesis is that patients with homogeneous emphysema behave differently compared to heterogeneous emphysema with respect to exercise capacity. A better understanding of this difference will allow the investigators to choose the best treatment for each type of patient. The main purpose of this study is to evaluate the change in exercise capacity measured by cycle ergometry in patients with severe emphysema after endoscopic lung volume reduction with coils (eLVR). As a secondary purpose, the investigators want to perform an exploratory, randomized study to compare the results of two different therapeutic approaches in a small sample of patients with homogeneous emphysema.